Unlocking the Secrets of Xenobiotic Toxicity: Metabolomics Sheds Light on the Gut Microbiome's Role
In a recent study, researchers from Florida International University reviewed the latest advancements in mass spectrometry and offer a roadmap of how MS analysis in relation to xenobiotics and metabolomics is heading in the future.
A recent review article published in TrAC Trends in Analytical Chemistry by scientists from Florida International University outlined the latest developments in the field of metabolomics and xenobiotics (1). The research team from Florida International University demonstrated in this review that mass spectrometry (MS) is at the forefront of metabolomics and xenobiotics, particularly when it comes to the new technologies being developed (1).
Gut bacteria , gut flora, microbiome. Bacteria inside the small intestine, concept, representation. 3D illustration. | Image Credit: © Anatomy Insider - stock.adobe.com
Toxic xenobiotics can have disastrous effects on the human body. Xenobiotics are foreign chemical compounds that can enter the body through passive or active transport and often end up in the gut when ingested (1). As a result, studying the interplay between resident gut microbiota and xenobiotics is important.
Metabolomics has emerged as a powerful tool in studying the multitude of metabolites concurrently (1). This method enables researchers to analyze and identify metabolic changes induced by xenobiotics with unprecedented precision.
The evolution of MS-based metabolomics platforms received significant focus in this review article because of these platforms’ ability to reveal metabolomic consequences of xenobiotic exposure (1). By employing these advanced techniques, scientists can now detect subtle alterations in the gut's chemical landscape, providing crucial insights into the toxicological effects of xenobiotics on both the host and its microbial inhabitants (1).
The research team also discussed recent applications in metabolomics, including highlighting research that successfully identified metabolic and microbial markers associated with xenobiotic exposure (1). The integration of metabolomics with gut microbiome profiling has proven to be particularly fruitful, offering a holistic view of how xenobiotics impact the delicate balance within the gut (1).
One of the main findings discussed in the review is the potential for reprogramming the gut microbiome to mitigate xenobiotic toxicity. The use of probiotics, prebiotics, and fecal microbiota transplantation (FMT) has shown promise in reducing the harmful effects of toxic xenobiotics (1). The reason why this approach is significant is because reducing the harmful effects of toxic xenobiotics can help address the most pressing xenobiotic-induced health concerns (1).
With MS-based metabolomics at our disposal, researchers are better equipped to identify markers of xenobiotic exposure, elucidate its mechanisms, and explore innovative interventions to safeguard our well-being (1).
Reference
(1) Jin, Y.; Chi, J.; LoMonaco, K.; Boon, A.; Gu, H. Recent review on selected xenobiotics and their impacts on gut microbiome and metabolome.TrAC Trends Anal. Chem. 2023, 166, 117155. DOI: 10.1016/j.trac.2023.117155
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
